Cobra Biologics Ltd
Cobra is a contract development and manufacturing organisation (CDMO) supporting the global Cell and Gene Therapy industry in the development and manufacture DNA and viral vectors from proof on pre-clinical through to clinical trials.
We provide a comprehensive service offering, with multi-functional and experienced project teams nurturing customers’ products from pre-clinical through to clinical GMP manufacture. For cell and gene therapy products we are able to produce DNA (HQ and GMP) and viral vectors (Adenovirus, AAV and lentiviral vectors). Cobra has also embarked on a £15m operations expansion to fast track our customers’ portfolios through to in-market supply.